相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways
Rong Wu et al.
CANCER CELL (2007)
Cellular functions of the BRCA tumour-suppressor proteins
S. J. Boulton
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
PIKK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia
Monica Prasad Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Expression profiling and individualisation of treatment for ovarian cancer
Roshan Agarwal et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential
Andrew Wiley et al.
CANCER (2006)
BRCA1 promoter methylation predicts adverse ovarian cancer prognosis
Jing Wang Chiang et al.
GYNECOLOGIC ONCOLOGY (2006)
BURCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study
M Thrall et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma
EJ Majdak et al.
CANCER (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assay
P Hardenbol et al.
GENOME RESEARCH (2005)
Allele quantification using molecular inversion probes (MIP)
YK Wang et al.
NUCLEIC ACIDS RESEARCH (2005)
Grading ovarian serous carcinoma using a two-tier system
A Malpica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Expression of BRCA I protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA I gene
C Wang et al.
JOURNAL OF PATHOLOGY (2004)
WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
M Al-Hussaini et al.
HISTOPATHOLOGY (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry
BA Werness et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin
JD Seidman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Pathology of ovarian carcinoma
JD Seidman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
Improved survival in women with BRCA-associated ovarian carcinoma
I Cass et al.
CANCER (2003)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients
T Schöndorf et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma -: 10-year follow-up data
JR Goffin et al.
CANCER (2003)
Homologous repair of DNA damage and tumorigenesis: the BRCA connection
M Jasin
ONCOGENE (2002)
Histopathologic features of genetically determined ovarian cancer
PA Shaw et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2002)
Microsatellite analysis of breast carcinoma and corresponding local recurrences
P Regitnig et al.
JOURNAL OF PATHOLOGY (2002)
Inhibition of JNK by cellular stress- and tumor necrosis factor α-induced AKT2 through activation of the NFκB pathway in human epithelial cells
ZQ Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gene expression profiles, of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers
AA Jazaeri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability
JR Jass et al.
EUROPEAN JOURNAL OF CANCER (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
RE Bristow et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
M Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
HA Risch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Phosphatidylinositol 3-kinases in tumor progression
D Roymans et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
β-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
M Saegusa et al.
BRITISH JOURNAL OF CANCER (2001)
BRCA1 and BRCA2 mutations in ovarian cancer:: Covariation with specific cytogenetic features
A Koul et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2000)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
J Boyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Histopathologic grading of ovarian carcinoma: A review and proposal
SG Silverberg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2000)
分享论文
